Raltegravir b-D-glucuronide methyl ester

Ref. 3D-MR29156

Informations sur le produit

• Nom: Raltegravir b-D-glucuronide methyl ester
• Synonymes: 4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl ]-6-oxopyrimidin-5-yl ?-D-Glucopyranosiduronic Acid Methyl Ester
• Marque: Biosynth
• Description: Raltegravir is an HIV protease inhibitor that belongs to the class of glycosylated polymers. This compound is synthesized by a click modification of d-glucose with a methyl group and then fluorinated. The sugar moiety is attached to the backbone through a glycosyl linkage, which results in the formation of a complex carbohydrate. Raltegravir b-D-glucuronide methyl ester is soluble in water, alcohols, and organic solvents. It has been shown to be active against HIV type 1 strains resistant to other drugs. The synthesis of this compound was custom designed for high purity and high yield.

Propriétés chimiques

• Masse moléculaire: 634.57 g/mol
• Formule: C₂₇H₃₁FN₆O₁₁
• Degré de pureté: Min. 95%